In which type of cardiac valve replacement surgeries, patients will be given anticoagulant therapy lifelong t… - RUHS, Jaipur, PB B.Sc Nursing Entrance-2019

RUHS, Jaipur, PB B.Sc Nursing Entrance-2019

Medical & Surgical Nursing

Medium

Appeared in: RUHS, Jaipur, PB B.Sc Nursing Entrance-2019

Explanation

Mechanical heart valves are constructed from non-biological, synthetic materials like pyrolytic carbon and metal alloys.
The body's immune and clotting systems recognize these materials as foreign, which activates the coagulation cascade and leads to a high risk of thrombus (blood clot) formation on the valve.
To prevent life-threatening thromboembolic events such as stroke or valve obstruction, patients with mechanical valves must take anticoagulant medication (like warfarin) for the rest of their lives.
These valves are highly durable but come with the significant trade-off of requiring lifelong blood thinner therapy and its associated monitoring and risks.

Option B: A porcine valve is a bioprosthetic valve made from pig heart tissue. Biological tissues are far less thrombogenic than synthetic materials.
Option C: An allograft (or homograft) is a valve taken from a human donor. It is the most biocompatible option and has a very low risk of causing blood clots.
Option D: A bovine valve is a bioprosthetic valve made from the pericardial tissue of a cow. Like porcine valves, it is made of biological material and does not typically require lifelong anticoagulation.

Clinical Relevance

Nursing practice connection: Knowing Anticoagulation therapy for cardiac valve replacements helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
Patient education is a critical nursing responsibility for individuals with mechanical valves. Nurses must thoroughly teach about medication adherence, regular INR monitoring, signs of bleeding or clotting, and dietary considerations (consistent Vitamin K intake) to ensure patient safety.
A patient's lifestyle, age, and comorbidities heavily influence the choice of valve. For example, a mechanical valve is often preferred for younger patients due to its durability, while a bioprosthetic valve may be chosen for older patients to avoid the risks of lifelong anticoagulation.
What if? If a female patient of childbearing age requires a valve replacement, a bioprosthetic valve (like porcine or bovine) is often recommended. This is because warfarin, the standard anticoagulant for mechanical valves, is a known teratogen and poses significant risks during pregnancy. A bioprosthetic valve avoids the need for lifelong warfarin, making future pregnancy safer.

How to Approach the Question

First, identify the key terms in the question: 'lifelong anticoagulant therapy' and 'cardiac valve replacement'. The question asks which valve type mandates this specific long-term treatment.
Next, recall the main categories of prosthetic heart valves: mechanical and biological (bioprosthetic/tissue).
Differentiate between the materials. Mechanical valves are made of artificial, non-biological materials (carbon, metal). Biological valves are made from animal tissue (porcine, bovine) or human tissue (allograft).
Apply the core physiological principle: The body's clotting system reacts strongly to foreign, non-biological surfaces. Therefore, artificial valves will have a high risk of clot formation.
Evaluate the options based on this principle. 'Mechanical valve' is the only option made of artificial material. 'Porcine', 'allograft', and 'bovine' are all biological.
Conclude that the mechanical valve is the only one that necessitates lifelong anticoagulation to counteract the high risk of thrombosis.

Concept Tested & Keywords

Concept Tested: Anticoagulation therapy for cardiac valve replacements
Stem keywords: cardiac valve replacement, anticoagulant therapy, lifelong, thrombus formation
Lead-in keywords: In which type

Q43IOSYuPqVfYndrcbfOG6

E6 Medicine Davidson Principles Practice 24e pp. 546-548, 547-549

E6 Nursing Brunner Adult Health 3SA Vol 1 Part 3 p. 6-8